Compare Mesoblast Limited (MESO) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Global X Uranium ETF — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Global X Uranium ETF trades at $40.59. The key difference: Mesoblast Limited is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals.
| MESO | URA | |
|---|---|---|
Market Cap | $2.17B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $20.96 | $61.81 |
52-Week Low | $12.88 | $36.45 |
Enterprise Value | $2.17B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
